AMSBIO launches clinical grade stem cell culture medium for regenerative medicine

AMSBIO announces the launch of StemFit® Basic03 clinical grade stem cell culture for regenerative medicine.

Provided as a animal-origin free, ready to use media for cell therapy applications, StemFit® AK03N which is the Japanese version of Basic03 has already been accepted by Pharmaceuticals and Medical Devices Agency, Japan (PMDA) for retinal regenerative medicine clinical trials using human induced pluripotent stem cells (hiPSCs).

In an independent study, media of different formulations were compared with StemFit® Basic03 for culturing iPS cells. The resultant research data showed, iPS cells cultured with StemFit® Basic03 offered higher cell proliferation, lower lactate accumulation and demonstrated better homogeneity of gene expression compared with iPS cells cultured with 4 other media.

Completely free of animal- and human-derived components StemFit® Basic03 is proven to provide highly stable and reproducible culture condition for Induced Pluripotent Stem and Embryonic Stem cells under feeder-free conditions during the reprogramming, expansion and differentiation phases of stem cell culture. StemFit® Basic03 combines high colony forming efficiency with lower than standard media volume consumption to offer cost effective colony expansion when compared to leading competitors.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    AMS Biotechnology. (2018, June 06). AMSBIO launches clinical grade stem cell culture medium for regenerative medicine. News-Medical. Retrieved on May 24, 2019 from https://www.news-medical.net/news/20180606/AMSBIOc2a0launches-clinical-grade-stem-cell-culturec2a0medium-for-regenerative-medicine.aspx.

  • MLA

    AMS Biotechnology. "AMSBIO launches clinical grade stem cell culture medium for regenerative medicine". News-Medical. 24 May 2019. <https://www.news-medical.net/news/20180606/AMSBIOc2a0launches-clinical-grade-stem-cell-culturec2a0medium-for-regenerative-medicine.aspx>.

  • Chicago

    AMS Biotechnology. "AMSBIO launches clinical grade stem cell culture medium for regenerative medicine". News-Medical. https://www.news-medical.net/news/20180606/AMSBIOc2a0launches-clinical-grade-stem-cell-culturec2a0medium-for-regenerative-medicine.aspx. (accessed May 24, 2019).

  • Harvard

    AMS Biotechnology. 2018. AMSBIO launches clinical grade stem cell culture medium for regenerative medicine. News-Medical, viewed 24 May 2019, https://www.news-medical.net/news/20180606/AMSBIOc2a0launches-clinical-grade-stem-cell-culturec2a0medium-for-regenerative-medicine.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post
You might also like... ×
AMSBIO's experimental cell lines help enhance search for new CAR T therapies